Search research articles
Contact Us
Filters
Showing results (741-750 of 853) with videos related to
Page
of 86
Sort By:
British Journal of Cancer
|
November 12, 2015
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials
E Geuna, D Roda, S Rafii, et al.
Current Eye Research
|
January 6, 2022
Delivering Endothelial Keratoplasty Grafts: Modern Day Transplant Devices
Mohit Parekh, Vito Romano, Kareem Hassanin, et al.
British Journal of Cancer
|
August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study
C N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2012
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer
S B Kaye, C J Poole, A Dańska-Bidzińska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
S B Kaye, G M Mead, S Fossa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2012
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis
Bradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
Cancer Research
|
May 15, 1987
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study
G Stoter, R Sylvester, D T Sleijfer, et al.
Science (New York, N.Y.)
|
October 14, 2017
Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water
Joshua A Riback, Micayla A Bowman, Adam M Zmyslowski, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer
G Stoter, R Sylvester, D T Sleijfer, et al.
Drug Discovery Today
|
December 8, 2009
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Craig P Carden, Debashis Sarker, Sophie Postel-Vinay, et al.
Page
of 86
Search research articles
Search
Showing results (741-750 of 853) with videos related to
Sort By:
Page
of 86
British Journal of Cancer
|
November 12, 2015
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials
E Geuna, D Roda, S Rafii, et al.
Current Eye Research
|
January 6, 2022
Delivering Endothelial Keratoplasty Grafts: Modern Day Transplant Devices
Mohit Parekh, Vito Romano, Kareem Hassanin, et al.
British Journal of Cancer
|
August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study
C N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2012
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer
S B Kaye, C J Poole, A Dańska-Bidzińska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
S B Kaye, G M Mead, S Fossa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2012
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis
Bradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
Cancer Research
|
May 15, 1987
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study
G Stoter, R Sylvester, D T Sleijfer, et al.
Science (New York, N.Y.)
|
October 14, 2017
Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water
Joshua A Riback, Micayla A Bowman, Adam M Zmyslowski, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer
G Stoter, R Sylvester, D T Sleijfer, et al.
Drug Discovery Today
|
December 8, 2009
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Craig P Carden, Debashis Sarker, Sophie Postel-Vinay, et al.
Page
of 86